Assignee
INTELGENX CORP
CA·18 granted patents·30 pending applications·236 citations·filing 2002–2025
Top patents by PatentIndex Score
48 records- 0198US7674479B2Sustained-release bupropion and bupropion/mecamylamine tabletsINTELGENX CORP·Filed 2007·Granted Mar 9, 2010·137 cites·10 claims
- 0294US10272038B2Film dosage form with extended release mucoadhesive particlesINTELGENX CORP·Filed 2017·Granted Apr 30, 2019·9 cites·28 claims
- 0393US11471406B2Oral film formulation for modulating absorption profileINTELGENX CORP·Filed 2020·Granted Oct 18, 2022·3 cites·20 claims
- 0492US9668970B2Film dosage form with extended release mucoadhesive particlesINTELGENX CORP·Filed 2014·Granted Jun 6, 2017·11 cites·20 claims
- 0590US11033493B2Film dosage form with extended release mucoadhesive particlesINTELGENX CORP·Filed 2018·Granted Jun 15, 2021·5 cites·20 claims
- 0690US10828254B2Oral film formulation for modulating absorption profileINTELGENX CORP·Filed 2018·Granted Nov 10, 2020·4 cites·20 claims
- 0789US10722476B2Device and method of treating conditions associated with neuroinflammationINTELGENX CORP·Filed 2018·Granted Jul 28, 2020·3 cites·12 claims
- 0888US11602504B2Lipophilic active oral film formulation and method of making the sameINTELGENX CORP·Filed 2019·Granted Mar 14, 2023·4 cites·17 claims
- 0986US9949934B1Device and method of treating conditions associated with neuroinflammationINTELGENX CORP·Filed 2016·Granted Apr 24, 2018·5 cites·3 claims
- 1086US2026097002A1Method of treatment and device for the improved bioavailability of leukotriene receptor antagonistsINTELGENX CORP·Filed 2025·Application pending·0 cites
- 1185US11648212B2Loxapine film oral dosage formINTELGENX CORP·Filed 2018·Granted May 16, 2023·3 cites·12 claims
- 1284US7132113B2Flavored filmINTELGENX CORP·Filed 2002·Granted Nov 7, 2006·42 cites·36 claims
- 1383US10610528B2Solid oral film dosage forms and methods for making sameINTELGENX CORP·Filed 2017·Granted Apr 7, 2020·3 cites·10 claims
- 1483US2025120908A1Oral film formulation for modulating absorption profileINTELGENX CORP·Filed 2024·Application pending·0 cites
- 1581US9717682B2Solid oral film dosage forms and methods for making sameINTELGENX CORP·Filed 2013·Granted Aug 1, 2017·3 cites·30 claims
- 1679US12156937B2Oral film formulation for modulating absorption profileINTELGENX CORP·Filed 2022·Granted Dec 3, 2024·0 cites·20 claims
- 1778US9301948B2Instantly wettable oral film dosage form without surfactant or polyalcoholINTELGENX CORP·Filed 2014·Granted Apr 5, 2016·4 cites·20 claims
- 1872US2023201130A1Lipophilic active oral film formulation and method of making the sameINTELGENX CORP·Filed 2023·Application pending·0 cites
- 1971US2026014136A1Lipophilic active oral film formulation and method of making the sameINTELGENX CORP·Filed 2025·Application pending·0 cites
- 2068US2023248660A1Method of preparing loxapine film oral dosage formINTELGENX CORP·Filed 2023·Application pending·0 cites
- 2167US11957785B2Film dosage form with extended release mucoadhesive particlesINTELGENX CORP·Filed 2021·Granted Apr 16, 2024·0 cites·20 claims
- 2267US2022362164A1Method of treatment and device for the improved bioavailability of leukotriene receptor antagonistsINTELGENX CORP·Filed 2022·Application pending·0 cites
- 2367US2022395452A1Method of treatment and device for the improved bioavailability of leukotriene receptor antagonistsINTELGENX CORP·Filed 2022·Application pending·0 cites
- 2466US2024139101A1Advanced oral film formulationsINTELGENX CORP·Filed 2023·Application pending·0 cites
- 2566US2019247505A1Film dosage forms containing amorphous active agentsINTELGENX CORP·Filed 2019·Application pending·0 cites
- 2663US2026048043A1High loading oral film formulation with improved bioavailabilityINTELGENX CORP·Filed 2023·Application pending·0 cites
- 2762US2019209459A1Film dosage form with extended release mucoadhesive particlesINTELGENX CORP·Filed 2019·Application pending·0 cites
- 2861US2023225965A1Oral films with flavor entrapmentINTELGENX CORP·Filed 2023·Application pending·0 cites
- 2961US2019290595A1Device and method of treating conditions associated with neuroinflammationINTELGENX CORP·Filed 2019·Application pending·0 cites
- 3059US2019133925A1Method of treatment and device for the improved bioavailability of leukotriene receptor antagonistsINTELGENX CORP·Filed 2018·Application pending·0 cites
- 3159US2023404937A1Novel disintegration oral film formulation with a controlled or sustained active releaseINTELGENX CORP·Filed 2023·Application pending·0 cites
- 3258US2018250240A1Method of treatment and device for the improved bioavailability of leukotriene receptor antagonistsINTELGENX CORP·Filed 2018·Application pending·0 cites
- 3357US12440472B2Stable tryptamine oral filmsINTELGENX CORP·Filed 2022·Granted Oct 14, 2025·0 cites·18 claims
- 3457US2024245603A1High loading oral film formulationINTELGENX CORP·Filed 2022·Application pending·0 cites
- 3557US2016324773A1Film dosage forms containing amorphous active agentsINTELGENX CORP·Filed 2016·Application pending·0 cites
- 3655US12303501B2Lipophilic active oral film formulation and method of making the sameINTELGENX CORP·Filed 2019·Granted May 20, 2025·0 cites·20 claims
- 3754US2016243036A1Film dosage forms containing amorphous active agentsINTELGENX CORP·Filed 2015·Application pending·0 cites
- 3854US2020215063A1Solid oral film dosage forms and methods for making sameINTELGENX CORP·Filed 2020·Application pending·0 cites
- 3953US2024189331A1Novel tryptamine oral film formulationINTELGENX CORP·Filed 2022·Application pending·0 cites
- 4052US2007190139A1Delayed release pharmaceutical oral dosage form and method of making sameINTELGENX CORP·Filed 2006·Application pending·0 cites
- 4150US2020138885A1Lipophilic active oral film formulation and method of making the sameINTELGENX CORP·Filed 2019·Application pending·0 cites
- 4249US2019314293A1Loxapine film oral dosage formINTELGENX CORP·Filed 2019·Application pending·0 cites
- 4349US2019231685A1Antihistamine oral film dosage form and method of administrating sameINTELGENX CORP·Filed 2019·Application pending·0 cites
- 4445US2018078549A1Solid oral film dosage forms and methods for making sameINTELGENX CORP·Filed 2017·Application pending·0 cites
- 4545US2018110724A1Film dosage form with multimodal and particle size distributionsINTELGENX CORP·Filed 2017·Application pending·0 cites
- 4640US2017216220A1Loxapine film oral dosage formINTELGENX CORP·Filed 2016·Application pending·0 cites
- 4736US2017258710A1Montelukast transmucosal filmINTELGENX CORP·Filed 2016·Application pending·0 cites
- 4834US2016220480A1Oral dosage film exhibiting enhanced mucosal penetrationINTELGENX CORP·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →